Joel S. Schuman
28Patents
4h-index
32Co-inventors
63Inventor score
Filing activity: Apr 29, 1992 → Sep 12, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5321501A | Method and apparatus for optical imaging with means for controlling the longitudinal range of the sample | Electricity | 1,175 | Expired |
| US7992999B2 | Automated assessment of optic nerve head with spectral domain optical coherence tomography | Physics | 7 | Active |
| US8712505B2 | Automated macular pathology diagnosis in three-dimensional (3D) spectral domain optical coherence tomography (SD-OCT) images | Physics | 5 | Active |
| US9895419B2 | Goblet cell replacement therapy | Human Necessities | 4 | Active |
| US6503892B2 | Method of using matrix metalloproteinase inhibitors in filtering blebs following glaucoma filtering surgery and in the treatment of ischemic damage to the retina and optic nerve | Human Necessities | 3 | Expired |
| US9180167B2 | Activators of CXCR3 for the treatment of angiopathies of the eye | Human Necessities | 3 | Active |
| US8831304B2 | Blood vessel segmentation with three-dimensional spectral domain optical coherence tomography | Physics | 3 | Active |
| US10575723B2 | Mapping of internal features on en face imagery | Human Necessities | 1 | Active |
| US10813549B2 | Optical coherence tomography as a rapid, accurate, non-contact method of visualizing the palisades of Vogt | Physics | 1 | Active |
| US9514513B2 | Establishing compatibility between two- and three-dimensional optical coherence tomography scans | Human Necessities | 1 | Active |
| US11246838B2 | Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery | Human Necessities | 1 | Active |
| US9980641B2 | Optical coherence tomography as a rapid, accurate, non-contact method of visualizing the palisades of Vogt | Physics | 1 | Active |
| US9844315B2 | Signal normalization among multiple optical coherence tomography devices | Physics | 1 | Active |
| US9452200B2 | Activators of CXCR3 for the treatment of angiopathies of the eye | Human Necessities | 1 | Active |
| US8911089B2 | Normalization of retinal nerve fiber layer thickness measurements made by time domain-optical coherence tomography | Physics | 1 | Active |
| US11484515B2 | Thermoresponsive hydrogel containing polymer microparticles for controlled drug delivery to the ear | Human Necessities | 0 | Active |
| US11730360B2 | Optical Coherence Tomography as a rapid, accurate, non-contact method of visualizing the palisades of Vogt | Physics | 0 | Active |
| US9872889B2 | Activators of CXCR3 for the treatment of angiopathies of the eye | Human Necessities | 0 | Active |
| US12396959B2 | Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery | Human Necessities | 0 | Active |
| US11406687B2 | Activators of CXCR3 for the treatment of angiopathies of the eye | Human Necessities | 0 | Active |
| US8815946B2 | Inhibition of proliferation and fibrotic response of activated corneal stromal cells | Human Necessities | 0 | Active |
| US10561710B2 | Goblet cell replacement therapy | Human Necessities | 0 | Active |
| US12329730B2 | Thermoresponsive hydrogel containing polymer microparticles for controlled drug delivery | Human Necessities | 0 | Active |
| US11170480B2 | Image enhancement using virtual averaging | Physics | 0 | Active |
| US10950353B2 | Systems and methods for disease progression modeling | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.